RG14921 is used as a non-competitive inhibitor of epidermal growth factor (EGF) receptor tyrosine kinase activity with respect to both ATP and peptide substrates; it also acts as a competitive inhibitor of ATP and a non-competitive inhibitor of peptide substrates in the context of cAMP-dependent protein kinase, demonstrating potent inhibitory effects on both kinase activities.